IntelliPharmaCeutics International (IPCIF)
OTHER OTC:IPCIF
IPCIF
IntelliPharmaCeutics International
RESEARCH TOOLSreports
Holding IPCIF?
Track your performance easily

IntelliPharmaCeutics International (IPCIF) Income Statement

144 Followers

IntelliPharmaCeutics International Income Statement

Last quarter (Q3 2023), IntelliPharmaCeutics International's total revenue was $68.72K, an increase of 260.38% from the same quarter last year. In Q3, IntelliPharmaCeutics International's net income was $-1.89M. See IntelliPharmaCeutics International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Nov 22Nov 21Nov 20Nov 19Nov 18
Total Revenue
$ 838.51K$ 65.73K-$ 1.40M$ 3.48M$ 1.71M
Cost of Revenue
$ 873.72K---$ 33.07K$ 124.87K
Gross Profit
$ -35.20K$ 65.73K-$ 1.40M$ 3.45M$ 1.59M
Operating Expense
$ 2.54M$ 2.92M$ 4.17M$ 6.08M$ 11.28M$ 14.91M
Operating Income
$ -2.58M$ -2.85M$ -4.17M$ -4.68M$ -7.83M$ -13.33M
Net Non Operating Interest Income Expense
$ -234.10K$ -291.62K$ 549.30K$ 969.65K$ 233.98K$ 429.81K
Other Income Expense
$ 483.04K$ -44.44K$ -536.97K$ 2.29M$ -21.08K$ 8.59K
Pretax Income
$ -3.17M$ -2.89M$ -5.26M$ -3.36M$ -8.09M$ -13.75M
Tax Provision
$ 5.34K$ 5.34K$ -114.19K$ 32.83K$ -5.36K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -3.17M$ -2.89M$ -5.15M$ -3.39M$ -8.08M$ -13.75M
Basic EPS
$ -0.10$ -0.09$ -0.17$ -0.14$ -0.37$ -2.89
Diluted EPS
$ -0.10$ -0.09$ -0.17$ -0.14$ -0.37$ -2.89
Basic Average Shares
$ 132.37M$ 33.09M$ 29.43M$ 23.56M$ 21.58M$ 4.76M
Diluted Average Shares
$ 132.37M$ 33.09M$ 29.43M$ 23.56M$ 21.58M$ 4.76M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.42M$ 2.92M$ -4.17M$ -6.08M$ -11.32M$ -15.04M
Net Income From Continuing And Discontinued Operation
$ -3.17M$ -2.89M$ -5.15M$ -3.39M$ -8.08M$ -13.75M
Normalized Income
$ -1.97M$ -2.17M$ -4.86M$ -4.93M$ -8.10M$ -10.10M
Interest Expense
------
EBIT
$ -2.93M$ -2.60M$ -4.71M$ -2.39M$ -7.84M$ -13.49M
EBITDA
$ -2.50M$ -2.39M$ -4.45M$ -1.97M$ -7.34M$ -12.88M
Currency in USD

IntelliPharmaCeutics International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis